These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 25043390

  • 1. Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer.
    Halec G, Alemany L, Lloveras B, Schmitt M, Alejo M, Bosch FX, Tous S, Klaustermeier JE, Guimerà N, Grabe N, Lahrmann B, Gissmann L, Quint W, Bosch FX, de Sanjose S, Pawlita M, Retrospective International Survey and HPV Time Trends Study Group, Retrospective International Survey and HPV Time Trends Study Group.
    J Pathol; 2014 Dec; 234(4):441-51. PubMed ID: 25043390
    [Abstract] [Full Text] [Related]

  • 2. Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer.
    Halec G, Schmitt M, Dondog B, Sharkhuu E, Wentzensen N, Gheit T, Tommasino M, Kommoss F, Bosch FX, Franceschi S, Clifford G, Gissmann L, Pawlita M.
    Int J Cancer; 2013 Jan 01; 132(1):63-71. PubMed ID: 22514107
    [Abstract] [Full Text] [Related]

  • 3. Concordance of HPV load and HPV mRNA for 16 carcinogenic/possibly carcinogenic HPV types in paired smear/tissue cervical cancer specimens.
    Halec G, Dondog B, Pawlita M, Schmitt M.
    Arch Virol; 2017 Nov 01; 162(11):3313-3327. PubMed ID: 28717857
    [Abstract] [Full Text] [Related]

  • 4. Are 20 human papillomavirus types causing cervical cancer?
    Arbyn M, Tommasino M, Depuydt C, Dillner J.
    J Pathol; 2014 Dec 01; 234(4):431-5. PubMed ID: 25124771
    [Abstract] [Full Text] [Related]

  • 5. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
    Andersson E, Kärrberg C, Rådberg T, Blomqvist L, Zetterqvist BM, Ryd W, Lindh M, Horal P.
    J Clin Virol; 2012 May 01; 54(1):61-5. PubMed ID: 22326759
    [Abstract] [Full Text] [Related]

  • 6. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX, Retrospective International Survey and HPV Time Trends Study Group.
    Lancet Oncol; 2010 Nov 01; 11(11):1048-56. PubMed ID: 20952254
    [Abstract] [Full Text] [Related]

  • 7. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
    Geraets D, Alemany L, Guimera N, de Sanjose S, de Koning M, Molijn A, Jenkins D, Bosch X, Quint W, RIS HPV TT Study Group.
    J Pathol; 2012 Dec 01; 228(4):534-43. PubMed ID: 22711526
    [Abstract] [Full Text] [Related]

  • 8. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F, Fusetti L, Rosini S, Caraceni D, Zappacosta R, Ciccocioppo L, Matteoli B, Halfon P, Malnati MS, Ceccherini-Nelli L.
    J Med Virol; 2013 Mar 01; 85(3):472-82. PubMed ID: 23280876
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors of human papillomavirus genotypes of invasive cervical carcinoma: an analytical cross-sectional study in lower north-east Thailand.
    Wongsena M, Suebsamran P, Panomket P, Tirat S, Wongsena P, Wanram S.
    J Med Assoc Thai; 2014 Apr 01; 97 Suppl 4():S12-9. PubMed ID: 24851559
    [Abstract] [Full Text] [Related]

  • 10. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
    Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P, Kisseljov F, Dürst M, Schneider A, von Knebel Doeberitz M.
    Cancer Res; 2008 Jan 01; 68(1):307-13. PubMed ID: 18172324
    [Abstract] [Full Text] [Related]

  • 11. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.
    Quddus MR, Manna P, Sung CJ, Kerley S, Steinhoff MM, Lawrence WD.
    Hum Pathol; 2014 Feb 01; 45(2):303-9. PubMed ID: 24355194
    [Abstract] [Full Text] [Related]

  • 12. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug 01; 42(8):823-33. PubMed ID: 2172419
    [Abstract] [Full Text] [Related]

  • 13. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study.
    Cuschieri KS, Cubie HA, Whitley MW, Gilkison G, Arends MJ, Graham C, McGoogan E.
    J Clin Pathol; 2005 Sep 01; 58(9):946-50. PubMed ID: 16126875
    [Abstract] [Full Text] [Related]

  • 14. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
    van Ham MA, Bakkers JM, Harbers GK, Quint WG, Massuger LF, Melchers WJ.
    J Clin Microbiol; 2005 Jun 01; 43(6):2662-7. PubMed ID: 15956381
    [Abstract] [Full Text] [Related]

  • 15. Biological relevance of human papillomaviruses in vulvar cancer.
    Halec G, Alemany L, Quiros B, Clavero O, Höfler D, Alejo M, Quint W, Pawlita M, Bosch FX, de Sanjose S.
    Mod Pathol; 2017 Apr 01; 30(4):549-562. PubMed ID: 28059099
    [Abstract] [Full Text] [Related]

  • 16. Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns.
    Schmitt M, Dalstein V, Waterboer T, Clavel C, Gissmann L, Pawlita M.
    Cancer Res; 2010 Jan 01; 70(1):249-56. PubMed ID: 20028865
    [Abstract] [Full Text] [Related]

  • 17. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL.
    Cancer; 2002 Apr 15; 94(8):2199-210. PubMed ID: 12001118
    [Abstract] [Full Text] [Related]

  • 18. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
    Nemes JA, Deli L, Nemes Z, Márton IJ.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep 15; 102(3):344-52. PubMed ID: 16920543
    [Abstract] [Full Text] [Related]

  • 19. Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases.
    Kasamatsu E, Cubilla AL, Alemany L, Chaux A, Tous S, Mendoza L, Paez M, Klaustermeier JE, Quint W, Lloveras B, de Sanjose S, Muñoz N, Bosch FX.
    J Med Virol; 2012 Oct 15; 84(10):1628-35. PubMed ID: 22930512
    [Abstract] [Full Text] [Related]

  • 20. HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.
    Gokhale PS, Sonawani A, Idicula-Thomas S, Kerkar S, Tongaonkar H, Mania-Pramanik J.
    J Med Virol; 2014 Jun 15; 86(6):968-74. PubMed ID: 24610458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.